Moreover, we found that treatment with DKK1, a specific inhibitor of Wnt/β-catenin signaling, diminished the migration ability and activity of Wnt/ β-catenin signaling in NSCLC cells induced by CTHRC1 overexpression. This evidence concerns the gene DKK1 and non-small cell lung carcinoma.